Uses of Atoronobi 20

Each Atoronobi 20 tablet contains 20mg of Atorvastatin as Atorvastatin calcium. Atorvastatin belongs to the group of drugs that inhibit HMG - CoA reductase.
Atorvastatin is a cholesterol-lowering drug. The drug inhibits the production of cholesterol in the liver by inhibiting a cholesterol-producing enzyme called HMG CoA reductase. The drug lowers the level of total cholesterol and LDL cholesterol in the blood (LDL cholesterol is considered a "bad" cholesterol that plays a major role in coronary heart disease). Lowering LDL cholesterol levels slows the progression and even reverses coronary heart disease. Unlike other drugs in its class, Atorvastatin can also lower blood triglyceride levels. High blood triglyceride levels are also associated with coronary heart disease.
Atoronobi 20 is used in the following cases:
Reduces total cholesterol, apolipoprotein B and triglycerides, LDL - cholesterol and increases HDL - cholesterol in patients with primary hypercholesterolemia; Used for patients with beta-lipoproteinemia without adequate response to diet; Reducing total cholesterol and LDL - cholesterol in patients with homozygous familial hypercholesterolemia. Do not use Atoronobi 20 in the following cases:
People who are sensitive to HMG-CoA reductase inhibitors; Patients with progressive liver disease or persistent elevations of serum transaminases with unknown etiology; Pregnant and lactating women.

Atoronobi 20 is to be taken orally at any time of the day and without regard to meals.
Dosage:
Treatment of hypercholesterolemia (non-familial and heterozygous familial) and mixed dyslipidemia: The recommended starting dose is 10 - 20 mg/time x 1 time. /day. Patients who need to reduce their LDL cholesterol significantly (more than 45%) can be started with a dose of 40 mg/time x 1 time/day. The therapeutic dose range of the drug is at 10 - 80mg once daily; After starting treatment and / or after increasing the dose of Atoronobi 20, it is necessary to evaluate blood lipid indexes within 2-4 weeks to adjust the dose accordingly; Homozygous hypercholesterolemia: Use 10 - 80 mg/day and note that it should be combined with other lipid-lowering measures; Combination therapy: Atorvastatin can be used in combination with resins to increase the therapeutic effect; Patients with renal impairment: No dose adjustment is required. Care should be taken to use Atoronobi 20 in full to avoid missed doses. In addition, if unfortunately forgot to take a dose of Atoronobi 20, the patient should notify the doctor for advice, do not arbitrarily combine doses. If you overdose and have unusual symptoms, the patient should also immediately notify the doctor for health monitoring and appropriate treatment.

Atoronobi 20 is generally well tolerated, side effects are usually mild and transient. Some side effects that may occur when using Atoronobi 20 are: Flatulence, constipation, indigestion, nausea, abdominal pain, vomiting, dizziness, headache. Patients should notify their doctor if they experience unusual side effects of Atoronobi 20 for instructions on handling.

Some things patients need to keep in mind before and while using Atoronobi 20 are:
Before starting treatment with Atorvastatin, it is important to rule out the causes of secondary dyslipidemia and measure the indicators. lipids. It is recommended to perform periodic dosing with intervals of not less than 4 weeks; During treatment with HMG-CoA reductase inhibitors, if creatine kinase is elevated, myositis develops, or serum liver enzymes are 3 times higher than the upper limit of normal, the dose should be reduced or stop taking Atoronobi; Use Atoronobi 20 with caution in patients with liver dysfunction, patients who drink a lot of alcohol; Patients should have a suitable diet before treatment with Atoronobi 20 and should maintain this diet throughout the course of taking the drug.

Some drug interactions Atoronobi 20 to note:
Indanedione, anticoagulants when combined with atorvastatin will increase bleeding time or prothrombin time. It is necessary to monitor prothrombin time in patients when using Atoronobi in combination with anticoagulants; Gemfibrozil, erythromycin, cyclosporin, immunosuppressants, niacin when used in combination with Atoronobi will increase the risk of myopathy; Co-administration of digoxin with Atorvastatin resulted in a slight increase in serum digoxin concentrations. Above is the answer to what disease Atoronobi 20 treats and the notes when using the drug. In the process of using the drug, patients need to pay special attention to listening and following the instructions from the doctor to bring the best treatment effect.